Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_assertion type Assertion NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_head.
- NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_assertion description "[Tissue microarray result showed that downregulation of CACNA2D3 was detected in (127/224, 56.7%) ESCCs, which was significantly associated with lymph node metastasis (P?=?0.01), TNM staging (P?=?0.003) and poor outcome of ESCC patients (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_provenance.
- NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_assertion evidence source_evidence_literature NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_provenance.
- NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_assertion SIO_000772 23560067 NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_provenance.
- NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_assertion wasDerivedFrom befree-2016 NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_provenance.
- NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_assertion wasGeneratedBy ECO_0000203 NP1066799.RAw86xGHumZgCVj5mtzX7UDfPyUyL0wBdGFH6s7Ga61ro130_provenance.